Abstract
Lipodystrophy is defined as a heterogeneous group of diseases characterized by a partial or complete reduction in body fat mass. It is associated, by unknown mechanisms, with the development of various metabolic complications such as insulin resistance, dyslipidemia, hypertension, hepatic steatosis and atherosclerosis. Previous studies have shown that adiponectin and leptin administration…